Business
Billionaire hedge fund investor William (Bill) Ackman, whose funds Pershing Square Capital Management have suffered double-digit losses this year, on Tuesday told investors that...
Hi, what are you looking for?
Billionaire hedge fund investor William (Bill) Ackman, whose funds Pershing Square Capital Management have suffered double-digit losses this year, on Tuesday told investors that...
Pfizer is negotiating a price of $370 to $380 for each share, a person familiar with the discussions said.
A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them...
From 2010, Valeant shares rose more than 10-fold to peak in August. Unfortunately, from a systemic perspective, just about every American is worse...
Valeant Issues Statement On Sales Of Company Stock as follow: Valeant Pharmaceuticals International, Inc. stated that 1, 297, 399 shares pledged to Goldman...
Bill Ackman is about to hold a call defending his position in Valeant Pharmaceuticals. And ahead of this call, Herbalife, the nutritional supplement company...
John Petrides, MD and portfolio manager at Point View Wealth Management, says it might not be a wise decision to follow Bill Ackman into...
Renaissance Technologies LLC, one of the world’s most successful and secretive hedge fund groups, with roughly $27 billion in assets, is closing an eight-year...
Bill Ackman’s Pershing Square Capital, got pounded in September. The hedge fund was the best-performing last year, returning 40.4%. Last month the fund’s publicly...